(Press-News.org) Higher levels in blood of the protein clusterin, also known as apolipoprotein J, are significantly associated with the prevalence and severity of Alzheimer's disease, but not with the risk of onset of new disease, according to a study in the April 6 issue of JAMA.
Clusterin levels have been found to be increased in brain and cerebrospinal fluid of patients with Alzheimer disease (AD), and have been suggested to be involved in the pathogenesis of AD. "Plasma clusterin was reported to be associated with brain atrophy, baseline disease severity, and rapid clinical progression in AD, suggesting its possible use as a biomarker of AD," according to background information in the article.
Elisabeth M. C. Schrijvers, M.D., of Erasmus MC University Medical Center, Rotterdam, the Netherlands, and colleagues examined the associations between plasma levels of clusterin and the prevalence, severity, and risk of AD. The study included analysis of data on plasma levels of clusterin measured at baseline (1997-1999) in 60 individuals with prevalent AD, a random sub-group of 926 participants, and an additional 156 participants diagnosed with AD during follow-up (average, 7.2 years) until January 2007.
The researchers found that the likelihood of prevalent AD increased with increasing plasma levels of clusterin, with the odds increased by 63 percent for every standard deviation increase in clusterin levels, after adjusting for age, sex, education level, apolipoprotein E status, diabetes, smoking, coronary heart disease, and hypertension. Among patients with AD, higher clusterin levels were associated with more severe disease.
There was no statistically significant association of plasma clusterin levels with new AD during total follow-up or with new AD within or after 3 years of baseline. Results for all-cause dementia and vascular dementia were similar.
"In conclusion, our data from the general population show that increased plasma clusterin levels are associated with prevalent AD and are higher in more severe cases of AD. However, increased levels of clusterin do not precede development of AD and therefore are not a potential early marker of subclinical disease," the authors write.
###
(JAMA. 2011;305[13]1322-1326. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To contact the corresponding author Monique M. B. Breteler, M.D., Ph.D., email m.breteler@erasmusmc.nl.
For More Information: Contact the JAMA/Archives Media Relations Department at 312-464-JAMA or email: mediarelations@jama-archives.org.
Blood biomarker associated with prevalence, severity of Alzheimer's, but not risk of development
2011-04-06
ELSE PRESS RELEASES FROM THIS DATE:
Risk of death from opioid overdose related to higher prescription dose
2011-04-06
In an analysis of opioid prescription patterns and deaths, receiving higher prescribed doses is associated with an increased risk of opioid overdose death, but receiving both as-needed and regularly scheduled doses is not associated with overdose risk, according to a study in the April 6 issue of JAMA.
The rate of overdose death has increased sharply in the United States in the past decade and overdose death is a pressing public health problem, according to background information in the article. "Between 1999 and 2007, the rate of unintentional overdose death in the United ...
The Latest Virtual Summit Press Release To Give Women Business Owners Less Stress And More Success.
2011-04-06
Six expert business coaches and consultants are launching a "virtual summit" designed to fit the busy schedules of women business owners. The Make it Happen! Virtual Summit kicks off April 19 and focuses on presenting information that can be implemented quickly into action steps leading to high-impact results.
The Make it Happen Virtual Summit is geared to women who are ready to strategically prioritize their business and life goals to enhance professional success and personal fulfillment with less stress. Topics include developing a powerful profit-boosting marketing ...
HIV-1 drug resistance mutations associated with increased risk of antiretroviral treatment failure
2011-04-06
An analysis of data from 10 studies indicates that the presence of low frequency (also called "minority") human immunodeficiency virus type 1 (HIV-1) drug resistance mutations, particularly those involving nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance, are significantly associated with an increased risk of first-line antiretroviral treatment failure, according to an article in the April 6 issue of JAMA.
Using traditional tests, the prevalence of transmitted drug resistance mutations is estimated to be between 8 percent and 16 percent among HIV-1 infected ...
Death rates after hospitalization down for oldest heart failure patients
2011-04-06
Death rates after hospitalization for heart failure have dropped for veterans age 80 and older, but rehospitalizations remain frequent, according to a study in the American Heart Association journal Circulation: Heart Failure.
Results of the study highlight a need to better identify which patients among the oldest are more likely to be rehospitalized not just for heart failure, but for any reason, said Rashmee Shah, M.D., lead author of the study and postdoctoral fellow in the Department of Health Research and Policy at Stanford University School of Medicine in Palo Alto, ...
AIT Becomes the First Software Vendor in American Translators Association's Member-Provider Program
2011-04-06
Advanced International Translations (AIT), a leading supplier of translation management software for agencies and freelancers, became the first member-provider software company in the American Translators Association (ATA).
ATA's Member-Provider Program was established to provide support to members in their practice of translation and interpreting. Vendors in the program are selected after careful review of the company's products, services, reliability, and value. The selection process includes feedback and recommendations from ATA members about the vendor and its products.
Participation ...
Off-label marketing of medicines in the US is rife but difficult to control
2011-04-06
Despite Federal Drug Administration regulation of the approval and use of pharmaceutical products, "off-label" marketing of drugs (for purposes other than those for which the drug was approved) has occurred in all aspects of the US health care system. In a study published in this week's PLoS Medicine, Aaron S. Kesselheim from Brigham and Women's Hospital, Boston, USA and colleagues report that the most common alleged off-label marketing practices also appear to be the most difficult to control through external regulatory approaches. They identified three main goals of alleged ...
Comprehensive approach can improve clinical care of Kenyan children
2011-04-06
A multifaceted approach that addressed deficiencies in clinical knowledge, skills, motivation, resources, and the organization of care was associated with improvements in practice for high mortality conditions in young children in rural Kenya compared with less comprehensive approaches.
This finding from a novel study by Philip Ayieko from the KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya, and colleagues, published in this week's PLoS Medicine, is important as it suggests that specific efforts are needed to improve pediatric care in rural areas of poor countries ...
Effects of pneumococcal vaccination program on pneumococcal carriage and invasive disease
2011-04-06
Using a cross-sectional study, Stefan Flasche and colleagues investigated the effects of the UK pneumococcal vaccination program on serotype-specific carriage and invasive pneumococcal disease.
There are more than 90 Streptococcus pneumoniae serotypes that can cause invasive pneumococcal disease (IPD). The pneumococcal conjugate vaccine PCV7 contains antigens from seven serotypes responsible for IPD. Immunization with PCV7 prevents both IPD disease and carriage of these seven serotypes, but after vaccination non-vaccine serotypes could colonize the nasopharynx. There ...
Ben Cohen: The Problem Solver for Company Energy Bill Expenditures
2011-04-06
For companies facing the ongoing challenge of energy related costs a New York based entrepreneur is offering instant lower pricing options via his Energy Deregulation Business Model. "The breakup of Ma Bell offered consumers the opportunity to shop for lower phone rates and that same situation is now available for energy consumers currently in the states of Texas, Connecticut, New Jersey, New York as well as parts of Pennsylvania and Illinois," said Ben Cohen.
Cohen's business solution (www.cohenenergysolutions.emexpower.com) allows clients to lock in on fixed rates ...
Sandia researchers merge gaming, simulation tools to create models for border security
2011-04-06
VIDEO:
Developed via funding from the Department of Homeland Security's Customs and Border Protection (CBP), the Borders High Level Model is a high-fidelity simulation and analysis program that aids policy and...
Click here for more information.
LIVERMORE, Calif. —With funding from the Department of Homeland Security's Customs and Border Protection (CBP), researchers at Sandia National Laboratories have developed a high-fidelity simulation and analysis program that aids ...